Yes, many clinicians transition patients between the two when weight loss plateaus, side effects become intolerable or supply issues arise
The majority of people have also reported muscle mass loss because the weight loss is so rapid
While danuglipron has shown good efficacy in a twice-daily formulation in phase 2b testing, we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space, he said
In addition, L-carnitine helps to remove toxic compounds from within the mitochondria, which can accumulate as a result of normal metabolic processes
Currently, AD patients with positive tau pathology exhibit poor responsiveness to anti-A antibody treatments, which are ineffective in reducing tau levels [106]
This risk was particularly concentrated in patients with pre-existing retinopathy and those experiencing rapid reductions in HbA1c